Return to the list
Latvia - Final Regulatory Action
Chloroform CAS number:
67-66-3
Date circular:
12/12/2004

Chemical name: Methane, trichloro-

Final regulatory action has been taken for the category: Industrial

Final regulatory action: The chemical is Severely Restricted

Use or uses prohibited by the final regulatory action:

1.Shall not be used in concentrations equal to or greater than 0.1% by weight in substances and preparations placed on the market for sale to the general public and/or in diffuse applications such as in surface cleaning and cleaning of fabrics.
2.Without prejudice to the application of other EU provisions on the classification, packaging and labelling of dangerous substances and preparations, the packaging of such substances and preparations containing them in concentrations equal to or greater than 0.1% shall be legibly and indelibly marked as follows: "For use in industrial installations only"
By way of derogation, this provision shall not apply to:
(a) Medical or veterinary products as defined by Directive 2001/82/EC and Directive 2001/83/EC;
(b) cosmetic products as defined by Directive 76/768/EEC

Use or uses that remain allowed:

All other uses not listed above.

The final regulatory action was based on a risk or hazard evaluation: Yes

Summary of the final regulatory action:

Shall not be used in concentrations equal to or greater than 0.1% by weight in substances and preparations placed on the market for sale to the general public and/or in diffusive applications such as in surface cleaning and cleaning of fabrics. Certain exceptions apply.

The reasons for the final regulatory action were relevant to: Human health

Summary of known hazards and risks to human health:

This compound has caused birth defects in two different animal species. In acute poisoning this compound primarily affects the central nervous system. Exposure to low doses over a long period may harm the liver, resulting in fatty liver and necrosis. Acute poisoning may also cause kidney damage.
Inhalation - Irritating when inhaled, higher concentrations cause dizziness, nausea and loss of consciousness, followed by death. Skin contact - the compound extracts the lipids of the skin and may give red and chapped skin. Eye contact - the liquid is irritating to the eyes. This compound is a suspected carcinogen.

Date of entry into force of the final regulatory action: 01/01/2001